Report error Found 34 Enz. Inhib. hit(s) with all data for entry = 7284
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 10nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 10nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 10nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 20nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 20nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 130nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 170nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 210nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 210nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 230nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 260nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 300nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 310nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 310nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 310nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 310nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 320nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 330nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 350nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 350nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 360nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 360nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 400nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 400nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 450nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 560nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 640nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 950nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 1.40E+3nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 16(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 1.50E+3nMT: 22°CAssay Description:Compound 1 was also assayed to determine the IC50 values for three
different kinases (PCTAIRE1, DYRK1a, and CDK2) in comparison to Gsk3beta. The ass...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 2.10E+3nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 2.90E+3nMT: 22°CAssay Description:Compound 1 was also assayed to determine the IC50 values for three
different kinases (PCTAIRE1, DYRK1a, and CDK2) in comparison to Gsk3beta. The ass...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 7.20E+3nMT: 22°CAssay Description:Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screenin...More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 2(Human)
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 3.60E+4nMT: 22°CAssay Description:Compound 1 was also assayed to determine the IC50 values for three
different kinases (PCTAIRE1, DYRK1a, and CDK2) in comparison to Gsk3beta. The ass...More data for this Ligand-Target Pair
